Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Qiu

Showing results (601-610 of 648) with videos related to

Pageof 65
Sort By:
American Journal of Cancer Research|July 10, 2019
Efficacy of cytokine-induced killer cell-based immunotherapy for hepatocellular carcinomaChang-Chang Jia, Yun-Hao Chen, Xiu-Rong Cai, et al.
Hepatobiliary Surgery and Nutrition|May 1, 2023
Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter studyWen-Tao Yan, Chao Li, Lan-Qing Yao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2019
A Recurrence Predictive Model for Thymic Tumors and Its Implication for Postoperative Management: a Chinese Alliance for Research in Thymomas Database StudyHui Liu, ZhiTao Gu, Bo Qiu, et al.
Translational Lung Cancer Research|August 13, 2025
A preliminary analysis of integrating thymosin α1 into concurrent chemoradiotherapy and consolidative immunotherapy in unresectable locally advanced non-small cell lung cancerHao-Ting Zhang, Fang-Jie Liu, Da-Quan Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|May 2, 2021
Hypo-fractionated radiotherapy with concurrent chemotherapy for locoregional recurrence of non-small cell lung cancer after complete resection: A prospective, single-arm, phase II study (GASTO-1017)NaiBin Chen, QiWen Li, SiYu Wang, et al.
Oncology Letters|December 2, 2015
High expression level of T-box transcription factor 5 predicts unfavorable survival in stage I and II gastric adenocarcinomaYan Zheng, Yuan-Fang Li, Wei Wang, et al.
Zhonghua Yi Xue Za Zhi|July 12, 2012
[Effect of Xuebijing injection treatment on acute respiratory distress syndrome: a multicenter prospective randomized control clinical trial]Song-qiao LIU, Rui-qiang ZHENG, Mao-qin LI, et al.
Signal Transduction and Targeted Therapy|November 3, 2025
Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational researchHai-Bo Qiu, Zhiyan Liang, Jing Yang, et al.
Travel Medicine and Infectious Disease|August 20, 2025
Mapping the global risk of chikungunya virus endemicity and autochthonous transmission following importationYu-Feng Yang, Yun-Bo Qiu, Qiang Xu, et al.
Plos One|April 5, 2014
Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patientsYan Zheng, Dan-dan Wang, Wei Wang, et al.
Pageof 65

Showing results (601-610 of 648) with videos related to

Sort By:
Pageof 65
American Journal of Cancer Research|July 10, 2019
Efficacy of cytokine-induced killer cell-based immunotherapy for hepatocellular carcinomaChang-Chang Jia, Yun-Hao Chen, Xiu-Rong Cai, et al.
Hepatobiliary Surgery and Nutrition|May 1, 2023
Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter studyWen-Tao Yan, Chao Li, Lan-Qing Yao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2019
A Recurrence Predictive Model for Thymic Tumors and Its Implication for Postoperative Management: a Chinese Alliance for Research in Thymomas Database StudyHui Liu, ZhiTao Gu, Bo Qiu, et al.
Translational Lung Cancer Research|August 13, 2025
A preliminary analysis of integrating thymosin α1 into concurrent chemoradiotherapy and consolidative immunotherapy in unresectable locally advanced non-small cell lung cancerHao-Ting Zhang, Fang-Jie Liu, Da-Quan Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|May 2, 2021
Hypo-fractionated radiotherapy with concurrent chemotherapy for locoregional recurrence of non-small cell lung cancer after complete resection: A prospective, single-arm, phase II study (GASTO-1017)NaiBin Chen, QiWen Li, SiYu Wang, et al.
Oncology Letters|December 2, 2015
High expression level of T-box transcription factor 5 predicts unfavorable survival in stage I and II gastric adenocarcinomaYan Zheng, Yuan-Fang Li, Wei Wang, et al.
Zhonghua Yi Xue Za Zhi|July 12, 2012
[Effect of Xuebijing injection treatment on acute respiratory distress syndrome: a multicenter prospective randomized control clinical trial]Song-qiao LIU, Rui-qiang ZHENG, Mao-qin LI, et al.
Signal Transduction and Targeted Therapy|November 3, 2025
Olverembatinib, a multikinase inhibitor that modulates lipid metabolism, in advanced succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 1b study and translational researchHai-Bo Qiu, Zhiyan Liang, Jing Yang, et al.
Travel Medicine and Infectious Disease|August 20, 2025
Mapping the global risk of chikungunya virus endemicity and autochthonous transmission following importationYu-Feng Yang, Yun-Bo Qiu, Qiang Xu, et al.
Plos One|April 5, 2014
Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patientsYan Zheng, Dan-dan Wang, Wei Wang, et al.
Pageof 65